Contrast-induced Nephropathy
📧 Sign up to get email alerts when something new happens for Contrast-induced Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-04-06Clinical Trial Update: Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial [Phase 4]
A Phase 4 trial (ERIN) evaluating erythropoietin for prevention of contrast-induced nephropathy has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-28Clinical Trial Update: The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy [NA]
A clinical trial evaluating sodium bicarbonate to prevent contrast-induced nephropathy was terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography [Phase 2, Phase 3]
This clinical trial update concerns using N-acetylcysteine to prevent contrast-induced nephropathy in critically ill patients undergoing con…
-
CLINICAL_TRIALS trial_result · 2008-12-16Clinical Trial Update: Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease [Phase 3]
A Phase 3 clinical trial evaluating whether N-acetylcysteine can prevent contrast-induced nephropathy after catheterization in diabetic pati…
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: Preventing Contrast Nephropathy With Sodium Bicarbonate in Patients With Pulmonary Edema,Heart Failure,Uncontrolled HTN [Phase 2]
Phase 2 trial update on preventing contrast-induced nephropathy with sodium bicarbonate in high-risk patients with pulmonary edema, heart fa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN) [Phase 3]
Phase 3 trial evaluating whether sodium bicarbonate solution lowers the incidence of contrast-induced nephropathy. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2008-08-05Clinical Trial Update: COOL RCN: Cooling to Prevent Radiocontrast Nephropathy [Phase 2, Phase 3]
The COOL RCN trial evaluating cooling to prevent radiocontrast nephropathy in Phase 2 and Phase 3 was terminated.
-
CLINICAL_TRIALS trial_result · 2008-05-08Clinical Trial Update: Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients
Completed clinical trial evaluating whether cystatin C can serve as an early biomarker of contrast-induced nephropathy in patients undergoin…
-
CLINICAL_TRIALS trial_result · 2008-03-13Clinical Trial Update: Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy [Phase 2]
A Phase 2 trial comparing acetazolamide versus sodium bicarbonate for prevention of contrast-induced nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: The Correlation Between Oxidative Stress and Indinated Contrast-Media Nephrotoxicity
A completed clinical trial investigated the relationship between oxidative stress and iodinated contrast-media–associated kidney injury (con…
-
CLINICAL_TRIALS trial_result · 2007-08-24Clinical Trial Update: Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention [Phase 2, Phase 3]
Iloprost was evaluated for prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography or PCI. The clin…
-
CLINICAL_TRIALS trial_result · 2007-07-12Clinical Trial Update: PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography [Phase 4]
A Phase 4 trial evaluating whether simvastatin reduces contrast-induced acute kidney injury in patients with renal insufficiency undergoing …
-
CLINICAL_TRIALS trial_result · 2007-06-27Clinical Trial Update: Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy [Phase 4]
Phase 4 trial evaluating acetylcysteine, theophylline, and their combination for prophylaxis of contrast-induced nephropathy.
-
CLINICAL_TRIALS trial_result · 2007-02-01Clinical Trial Update: Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn [NA]
Clinical trial update on using cystatin C–based estimation of glomerular filtration rate to prevent contrast-induced nephropathy with N-acet…
-
CLINICAL_TRIALS trial_result · 2006-11-27Clinical Trial Update: NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization [Phase 4]
Phase 4 trial comparing N-acetylcysteine versus ascorbic acid to prevent contrast-induced nephropathy in patients with renal insufficiency u…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography [Phase 4]
A Phase 4 trial comparing two iodinated contrast agents in renally impaired patients undergoing cardiac angiography has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-18Clinical Trial Update: Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction [Phase 2, Phase 3]
The document notes the completion of Phase 2 and Phase 3 clinical trials evaluating N-acetylcysteine for preventing contrast-induced nephrop…